Chinese buyer for a pharma manufacturer in Europe

Company to buy

• Size: large companies
• Revenue: 10 – 100 million EUR
• Location of the target company: Europe, preferably southern or eastern Europe
• Reason for acquisition: The buyer has started to look for suitable European targets, to establish a presence in Europe.
• #CFIE PHB051

Overview of this buyer for a pharmaceuticals manufacturer in Germany

The management of a large Chinese pharma company started looking for a pharma API/formulations manufacturing company to buy, in order to establish a presence in Europe. The buyer would prefer a medium-scale manufacturing facility with an R&D department, laboratory, quality control and warehouse.

Profile (strategy) of this pharma manufacturer company buyer

The buyer is one of the leading vertically integrated pharmaceutical companies in China focusing on the development, manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished formulations. The company owns large scale manufacturing facilities for the production of chemical synthesized, lyophilized, sterile crystallized and fermented APIs.

The company is quite large, with over 1 billion EUR in revenue, and significant export to the United States. The company has multiple manufacturing sites and over 20 sales subsidiaries all around the world. The company is well known for its aggressive R&D attitude, with over 2000 people committed to research and development of new drugs.

The buyer is starting now to search for opportunities, the company had not made any acquisitions in Europe yet. However, the company is already present in Europe, with over 50 approved products on the EU market.

Activities and products of an ideal target

The buyer company is specialized in research, manufacturing and sales/marketing of pharmaceutical products. Now the management started looking for an acquisition of a pharma manufacturing company, in order to start production in Europe.

The target company should be specialized in one of the following product categories:

• APIs
• finished formulations
• injectables
• oral solids
• injection powders
• ophthalmic solutions
• sprays
• ointments or similar.

The target company should preferably be based in the EU, Southern or Eastern Europe. Targets from the UK will not be considered. The target company should be a manufacturer, however, it is not necessary – distributors or research companies will also be a possibility. It is required though for the target to have a laboratory of control and warehousing capacities.

The target should be financially healthy, have qualified personnel, packaging capacity. Also, it is required to meet all regulatory requirements of the EU.

The goal of the buyer is to acquire a fully regulatory compliant pharmaceutical manufacturing/distribution company under running condition.

Highlights of the pharma manufacturer company buyer

• The buyer is a pharmaceutical company based in China, with an ambition to start production in Europe
• The target company should be any manufacturing site in Europe with necessary regulatory certifications
• The target would benefit from synergies with one of the top 50 pharma companies in the world

More information on this chinese buyer for a pharma manufacturer in Europe

Please get in touch if you are interested in learning more about this chinese buyer for a pharma manufacturer in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.